Neuspera secures $65m funding for neuromodulation technology trial
The funds will be used to conduct the SANS-UUI pivotal clinical study of miniaturised implantable neuromodulation technology platform
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Jul 21
The funds will be used to conduct the SANS-UUI pivotal clinical study of miniaturised implantable neuromodulation technology platform
07 Jul 21
AI has already been used in multiple areas of healthcare to improve on existing technology, and the future…
07 Jul 21
The funds will be utilised to advance the development of its platform to rapidly meet the requirement for…
30 Jun 21
The OH08A/B image sensors provide high resolution with excellent image quality for 10-12mm outer diameter endoscopes
16 Jun 21
aura6000 is developed to treat adult patients with moderate to severe obstructive sleep apnea
11 Jun 21
New findings around the AI prediction of genetic subtypes in pancreatic cancer tumours could be useful in cancer…
09 Jun 21
SpaceOAR Vue prostate hydrogel is an improvement on an original product from Augmentix Inc that led to it…
03 Jun 21
The neurostimulation market is set to reach a value of more than $22bn globally by 2026, driven largely…
02 Jun 21
The study represents the first randomised controlled trial on the use of exoskeleton physical therapy for patients with…
01 Jun 21
The new JV will develop single-use therapeutics products in the field of flexible medical endoscopy